Predictive device of thrombotic events

The company has developed a diagnostic clinical tool, Smart Clot, which allows to identify, through a sophisticated process, potential thrombotic and hemorrhagic risks, the main causes of cardiovascular diseases and the circulatory system. The system includes a diagnostic kit and analysis software and also allows monitoring the effectiveness of the anti-aggregating or anti-coagulant therapies administered.

Date of investment April, 2012

Offices Pordenone, Italy

Life Science

Founding team

Raul Pietrini

Pasquale Mosella